Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.68 | 16.11 |
| PEG Ratio (TTM) | 0.76 | 0.46 |
| P/S Ratio (TTM) | 2.66 | 4.13 |
| P/B Ratio (TTM) | 1.07 | 3.06 |
| P/FCF Ratio (TTM) | -3.93 | 15.65 |
| Price to 5YR AVG Earnings Ratio | N/A | 39.71 |
| Price to 5YR AVG FCF Ratio | N/A | 22.57 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -17.76% | 10.33% |
| ROE (TTM) | -33.83% | 19.16% |
| Net Profit Margin (TTM) | -69.35% | -44.55% |
| ROIC 5YR AVG | N/A | 24.56% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -602.92% | -196.94% | N/A |
| Revenue | 1.40% | 57.46% | N/A |
| Net Income | -611.23% | -195.12% | N/A |
| Cash Flow | -0.50% | 110.11% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.02 | 1.79 |
| Quick Ratio (TTM) | 1.02 | 1.68 |
| D/E Ratio (TTM) | 0.25 | 18.68 |
| Interest Coverage (TTM) | -2.46 | 18.51 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.75 | 2.91 |
| LTL to 5YR AVG FCF | N/A | 16.92 |
| Shares Outstanding Growth 5YR AVG | N/A | 17.03% |